We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Woodford Patient Capital Trust Plc | LSE:WPCT | London | Ordinary Share | GB00BVG1CF25 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 33.60 | 33.55 | 33.90 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
14/4/2016 09:58 | Wouldn't put it past him that since in the annual report he said something along the lines of "not doing another fund raising because no one could understand what the hell a C share issue is" He goes ahead and does a massive one on you because of the "market opportunity" in that the share price has decoupled so far away from the NAV. | liquidkid | |
13/4/2016 14:45 | Not exactly since I am a holder. But also not exactly because only when the NAV is up will he have done so. As I said, for now it is just more manic buying and selling by impatient large investors. Current NAV of 91.8p. | harveydee | |
12/4/2016 12:00 | I do wonder how many PI's have bought into this as an ISA idea. Also note that Oxford Nanopore have changed their pore for their sequencing unit - this should circumvent the patent issue that was previously flagged up by the liquid one. Odd that he didn't find that, after initially finding the negative news. I have been adding these for the last couple of months, it will also form part of this years ISA. | dr biotech | |
12/4/2016 11:32 | Agreed, I've noticed a couple of recos from people who were previously very negative. I don't think this premium can hold and if I was minded to trade now is a good time to sell. But then, this is a long term holding for me (i.e. 10 years), so I probably won't. | mad foetus | |
12/4/2016 11:21 | NAV has not gone up that dramatically, still at 91.5p. But it is interesting that the big institutional buyers seem to be back in force, pushing the trust to a generous premium to NAV. Their manic behaviour - bullish and bearish - is making this "patient" fund look less than dignified. I'm a holder, so not complaining but striving to be factual and objective rather than blinkered or cheerleading is key to successful investing. | harveydee | |
02/4/2016 10:27 | The news that additional capital wouldn't be sought at this time (presumably removing fear of a discounted placing) plus positive results coming out of the biotech sector (most recently Regeneron) seems to have lifted spirits.. | hutch_pod | |
01/4/2016 14:12 | A long unintelligible post from the kid who knows nothing. Why does he bother? His posts have had the opposite effect from the one he so desperately desires. | the air marshall | |
23/3/2016 13:24 | I've got another small-time unsuccessful investor/prophet for you I'm afraid. Here's what he had to say. "ceaserxzy 11 Mar'16 - 18:00 - 769 of 784 1 1 The fact sheet not looking pretty. The top three are all unquoted companies, whose value may have not reflected the market falls recently. The next few quoted ones, except for the purp, all hover around the year lows. This looks further to fall and should be in a reasonable discount to NAV, say 10% as most other closed end ITs." It hasn't fallen since your silly prediction, has it? No, it's only gone up 9% in 10 working days! | kpo115 | |
22/3/2016 13:56 | Sunflowers brighten the day :) | toffeeman | |
22/3/2016 11:58 | You mean emperor in the circumstances one could perhaps say "caveat emperor" | tournesol | |
22/3/2016 09:33 | Whoosh, up she goes again! Gosh, I forgot to tell you. I bought 4 million of these babies at 84.7p, as I told you at the time. When I looked in the mirror this morning I saw a world-class investor. Indeed a veritable "emporer" of the financial universe. Hee Hee! | pete_bane | |
19/3/2016 09:17 | LK very quiet, normally has a fair bit to bore on about ALM, up about 40% in March. Positive RNS couple of days back. | prewar | |
14/3/2016 23:02 | Mercia, 20% held by WPCT, have bought Enterprise Ventures that has some interesting holdings itself so increasing the potential and spreading the investment over more investments still. Pretty sure it will pay handsomely from these levels over 3 years +. The future belongs to new ideas, new tech, new solutions to problems and WPCT is a good place to look to take part in that in a diverse reduced risk fashion. | p1nkfish | |
14/3/2016 15:18 | NEIL WOODFORD MODERATOR says: Today 2:34 pm Hi Martin, my personal wealth is invested in the Woodford business and in the Woodford funds (including my pension). I have no other investments other than the house that I live in. No one needs to question his conviction here. | minerve | |
14/3/2016 14:25 | I am pretty sure that he has all his money invested in either the WPCT or his equity funds. He is doing a live webcast as I type. NEIL WOODFORD says: Today 2:00 pm Kelvin (and others that have asked similar questions), The weakness of the WPCT share price and NAV since the start of 2016 has been the product of the pretty severe sell-off in shares across healthcare, biotech and early-stage quoted stocks, both here in the UK and in the US. Much of this, we believe to be driven by short-term positioning and rotational activity amongst the fund management community. We don’t believe that it is driven by a correction of over-valuation, nor by a deterioration in fundamentals. We remain very pleased with the underlying progress of the businesses in which we have invested in the trust. Indeed, in what has been a pretty short space of time since launch, our expectations for the underlying performance of many businesses in the portfolio have been exceeded. This is a long-term vehicle. We hope to deliver good performance in the short-term but believe we should be judged over the 3 to 5 year time scale we have talked about consistently since launch. Kind regards Neil | dr biotech | |
14/3/2016 11:03 | Woody will get paid a performance fee here and so is directly exposed to the performance of the fund: he gets nothing until it makes 10% pa, after that he does very well. EDIT - just seen that the performance fee is paid in newly issues shares in WPCT, so the alignment is even greater. Rich people do invest in their own funds - look at Terry Smith at Fundsmith for example. | mad foetus | |
13/3/2016 12:39 | Why on earth would someone worth as much as Woody invest in a fund - he would buy individual socks methinks | toffeeman | |
12/3/2016 11:52 | anyone knows if Woodford has put any personal stake on this fund and if yes, how much? Hope his confidence is supported by his money. | ceaserxzy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions